Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Vasa ; 46(2): 116-120, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28045369

ABSTRACT

BACKGROUND: Insufficient evidence exists to support the safety of carotid endarterectomy (CEA) following intravenous thrombolysis (IVT) for acute ischaemic stroke. Our study aimed to report a single-centre experience of patients treated over a five-year period. PATIENTS AND METHODS: Departmental computerised databases were interrogated to identify patients who suffered an ischaemic stroke and subsequently underwent thrombolysis followed by CEA. Mortality and stroke within 30 days of surgery were defined as the primary outcome end points. RESULTS: Over a five-year period, 177 out of a total of 679 carotid endarterectomies (26 %) were performed in patients presenting with acute ischaemic stroke. Twenty-five patients (14 %) received IVT prior to CEA in the form of alteplase. Sixty percent of patients were male with a mean age of 68 years. Sixteen patients (64 %) underwent CEA within 14 days of IVT and the median interval between thrombolysis and CEA was 7.5 days (range, 3-50 days). One female patient died of a further intraoperative stroke within 30 days of surgery, yielding a mortality rate of 4 %. Two patients (8 %) suffered from cardiac complications postoperatively resulting in a short high dependency unit stay. Another two patients (8 %) developed local wound complications, which were managed conservatively without the need for re-operation. The median hospital length of stay was 4.5 days (range, 1-33 days). CONCLUSIONS: Our experience indicates that CEA post-thrombolysis has a low incidence of mortality. Further high quality evidence is required before CEA can be routinely recommended following IVT for acute ischaemic stroke.


Subject(s)
Brain Ischemia/drug therapy , Carotid Artery Diseases/surgery , Endarterectomy, Carotid , Fibrinolytic Agents/administration & dosage , Stroke/drug therapy , Thrombolytic Therapy , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/etiology , Brain Ischemia/mortality , Carotid Artery Diseases/complications , Carotid Artery Diseases/diagnosis , Carotid Artery Diseases/mortality , Endarterectomy, Carotid/adverse effects , Endarterectomy, Carotid/mortality , England , Female , Fibrinolytic Agents/adverse effects , Humans , Infusions, Intravenous , Length of Stay , Male , Medical Audit , Middle Aged , Registries , Retrospective Studies , Risk Factors , Stroke/diagnosis , Stroke/etiology , Stroke/mortality , Thrombolytic Therapy/adverse effects , Thrombolytic Therapy/mortality , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...